Position in ZYME
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$25,220,538
-$1,710,839 QoQ
Shares Held
1,007,210
-1.5% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
4.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capricorn Fund Managers Ltd holds $53,362,145 across 7 Biotechnology names. ZYME ranks #1 (47.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
This page
|
1,007,210 | $25,220,538 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
369,400 | $14,480,480 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
534,079 | $7,722,782 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
64,604 | $2,599,018 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
26,000 | $1,823,900 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
339,727 | $961,427 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
20,000 | $554,000 |
All Filings in ZYME
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,220,538 | 1,007,210 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $26,931,377 | 1,022,840 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||